← Leaderboards
Andrew H Kaplan
University Of California Los Angeles
$5,345,581
Attributed
$5,345,581
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $757.9K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$5,345,581 · 8
By mechanism
R01$4,571,178 · 5
P30$401,838 · 1
K24$267,238 · 1
R03$105,327 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- James U Bowie$13,389,252
- Mo Kwan Kang$3,420,661
- Jeffery F. Miller$9,975,729
- Kendall N Houk$14,756,097
- Michael L Prendergast$14,988,548
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsBehavioral /Social Science Research TagAids TherapyClinical ResearchTherapy ComplianceHealth Services Research TagCorrectional InstitutionsVirus ReplicationDimerSubstance Abuse Related DisorderTissue /Cell CultureHealth Care Service EvaluationAntiviral AgentsHuman SubjectPatient Care ManagementVirus LoadHuman Immunodeficiency VirusMolecular BiologyBiomedical FacilityGene MutationBiohazard ControlImmunopathologyPathologic ProcessAids
Grant awards (22)
Mentoring Junior Faculty: Access to HIV Care$39,300
K24 · FY2006 · MH · contact PI
Highthroughput Assay for Inhibitors of HIV PR Activation$32,327
R03 · FY2006 · AI · contact PI
KEY INTERACTIONS FOR HIV 1 RT STABILITY AND DIMERIZATION$291,000
R01 · FY2005 · AI
HIV Protease Activation and Viral Replication$278,640
R01 · FY2005 · GM
Mentoring Junior Faculty: Access to HIV Care$115,254
K24 · FY2005 · MH
High Throughput Assay of Inhibitors of HIV PR Activation$73,000
R03 · FY2005 · AI
HIV Protease Activation and Viral Replication$278,640
R01 · FY2004 · GM
Retroviral Genomic RNA Dimer Structure and Function$254,625
R01 · FY2004 · GM
Mentoring Junior Faculty: Access to HIV Care$112,684
K24 · FY2004 · MH
ADHERENCE TO HAART AMONG INCARCERATED SUBSTANCE USERS$674,927
R01 · FY2003 · DA
HIV Protease Activation and Viral Replication$290,015
R01 · FY2003 · GM
Retroviral Genomic RNA Dimer Structure and Function$254,625
R01 · FY2003 · GM
ADHERENCE TO HAART AMONG INCARCERATED SUBSTANCE USERS$556,455
R01 · FY2002 · DA
Retroviral Genomic RNA Dimer Structure and Function$254,625
R01 · FY2002 · GM
CORE--VIROLOGY/BSL3 TISSUE CULTURE$129,540
P30 · FY2002 · AI
ADHERENCE TO HAART AMONG INCARCERATED SUBSTANCE USERS$102,264
R01 · FY2002 · DA
ADHERENCE TO HAART AMONG INCARCERATED SUBSTANCE USERS$540,250
R01 · FY2001 · DA
CORE--VIROLOGY/BSL3 TISSUE CULTURE$129,540
P30 · FY2001 · AI
CORE--VIROLOGY/BSL3 TISSUE CULTURE$0
P30 · FY2001 · AI
ADHERENCE TO HAART AMONG INCARCERATED SUBSTANCE USERS$529,618
R01 · FY2000 · DA
RECOMBINANT L MONOCYTOGENES AS AN SIV VACCINE$265,494
R01 · FY2000 · AI
CORE--VIROLOGY/BSL3 TISSUE CULTURE$142,758
P30 · FY2000 · AI